Results 1 to 10 of 104

Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care

Dr. William S. Smith will discuss quality-life measurements, compare the difference between the government and private insurance when determining treatment and talk about the push for rationing of medical care by federal and state governments.

Local Control or Too Much Control? Balancing the Rights of Citizens and State and Local Governments

What’s the right balance between local, state and federal control? What about the rights of citizens — should these vary widely based on where one chooses to live? This panel will feature a lawmaker, policy expert and local government advocate to talk about what is happening in Michigan and across the nation on these issues.

Civil Asset Forfeiture in Michigan: The Case for Reform and How to Get it

Seizure and forfeiture are important parts of the criminal justice system. In principle, this process is helpful for taking away assets from criminals and goods obtained illegally. But it’s easily abused, and Michiganders deserve to have their property rights protected. This panel will feature points of views from law enforcement, researchers and legislators. The discussion will be on why Michigan should continue to reform its civil asset forfeiture system and how to get it right.

How Criminal Justice Works in Michigan

Criminal justice reform will continue to be a hot topic in Lansing this year, as lawmakers on the left and right advance various proposals for reforming the system. But in order to properly evaluate the potential for successful change, it’s important to understand the nuts and bolts of how the system currently operates.

Economic Freedom: What it is and Why it Matters

Public policy choices can have profound consequences on the decisions individuals make about their own opportunities — where to live, work, invest and raise families. What can government leaders do to influence those choices? Respect economic freedom.

Bail Reform: Improving Pretrial Release to Benefit Defendants and Taxpayers

Michigan’s system of bail and pretrial release is ripe for reform, but any changes to this complex structure require a thorough understanding of current practices and how they diverge from best practices. Analysts at the Mackinac Center and the ACLU of Michigan both published papers to inform the public about bail in our state, which they will present jointly.

The New Face of the FCC: QA with Chairman Ajit Pai

Ajit Pai is the Chairman of the Federal Communications Commission, but his philosophy is a bit different than many regulators. Pai’s regulatory philosophy values consumers, competition and markets over regulation, bureaucrats and central planning. His principles include being aware of “regulatory capture,” a free and fair system without dispensing favors and special treatment, flexible rulemaking, and rules which respect the laws of Congress.

Smart Regs for Smart Tech: How Government Can Allow Next Gen Internet Networks to Flourish

This panel will discuss issues related to the future of internet networks, including 5G cell service, “net neutrality” and broadband infrastructure. Panelists will also offer guidance on what governments at all levels — local, state and federal — should do (or not do) in relation to the future of internet connectivity and the spinoff technologies it makes possible.

Beer Glut: The Overregulation of Alcohol in Michigan

Michigan’s rules about alcohol production, distribution and sales are complex. The state has restrictions on what can be produced, a strict monopoly system for distribution and imposes price controls on sellers. Many of these regulations were originally crafted some 80 years ago in the post-Prohibition era.

Why Prescription Drugs Are So Expensive and What the State Can Do About It

In recent years the price consumers pay for many brand name prescription drugs and even some generics has increased. There are several factors behind these increases. One has to do with the type of the drugs being developed today and the smaller number of patients they target. Another involves middlemen that absorb many of the price discounts provided by drug makers. And a third has to do with the regulations coming from both Washington and the states.